share_log

Avenue Therapeutics | EFFECT: Others

SEC announcement ·  Feb 2 06:05
Summary by Moomoo AI
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more